Alexandrescu et al. reported PHOX2B immunoreactivity of less than 1% in 4/4 ETMR and 2/4 ATRT, as well as immunoreactivity in 3/6 pineoblastomas (two with 40%–50% immunopositivity).8 Here, PHOX2B is linked to pineoblastoma.